Expression of CD1d molecules by human Schwann cells and potential interactions with immunoregulatory invariant NK T cells

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5226-5235

  Im, Jin S ^a   Tapinos, Nikos ^b   Chae, Gue Tae ^c   Illarionov, Petr A ^d   Besra, Gurdyal S ^d   DeVries, George H ^e   Modlin, Robert L ^f   Sieling, Peter A ^f   Rambukkana, Anura ^b   Porcelli, Steven A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c The Catholic University of Korea   (South Korea)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN INFECTION; CELL CULTURE; CELL IMMORTALIZATION; CELL LINE; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; HELA CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; NATURAL KILLER T CELL; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; PATHOGENESIS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; TH2 CELL;

EID: 33749531373     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5226     Document Type: Article

References (60)

1. Yu, K. O., and S. A. Porcelli. 2005. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol. Lett. 100: 42-55.
2. Chen, Y. G., C. M. Choisy-Rossi, T. M. Holl, H. D. Chapman, G. S. Besra, S. A. Porcelli, D. J. Shaffer, D. Roopenian, S. B. Wilson, and D. V. Serreze. 2005. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 174: 1196-1204.
3. Gillessen, S., Y. N. Naumov, E. E. Nieuwenhuis, M. A. Exley, F. S. Lee, N. Mach, A. D. Luster, R. S. Blumberg, M. Taniguchi, S. P. Balk, et al. 2003. CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc. Natl. Acad. Sci. USA 100: 8874-8879.
4. Naumov, Y. N., K. S. Bahjat, R. Gausling, R. Abraham, M. A. Exley, Y. Koezuka, S. B. Balk, J. L. Strominger, M. Clare-Salzer, and S. B. Wilson. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98: 13838-13843.
5. Van Der Vliet, H. J., J. W. Molling, B. M. Von Blomberg, N. Nishi, W. Kolgen, A. J. Van Den Eertwegh, H. M. Pinedo, G. Giaccone, and R. J. Scheper. 2004. The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin. Immunol. 112: 8-23.
6. Hansen, D. S., and L. Schofield. 2004. Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells. Int. J. Parasitol. 34: 15-25.
7. Mirsky, R., and K. R. lessen. 1999. The neurobiology of Schwann cells. Brain Pathol. 9:293-311.
8. Winer, S., H. Tsui, A. Lau, A. Song, X. Li, R. K. Cheung, A. Sampson, F. Afifiyan, A. Elford, O. Jackowski, et al. 2003. Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive. Nat. Med. 9: 198-205.
9. Van Rhijn, I., L. H. Van den Berg, W. M. Bosboom, H. O. Otten, and T. Logtenberg. 2000. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain 123 (Pt. 10): 2020-2029.
10. Ottenhoff, T. H. 2002. Mycobacterium leprae and demyelination. Science 297: 1475-1476.
11. Job, C. K. 1989. Nerve damage in leprosy. Int. J. Lepr. Other Mycobact. Dis. 57: 532-539.
12. Rambukkana, A. 2004. Mycobacterium leprae-induced demyelination: a model for early nerve degeneration. Curr. Opin. Immunol. 16: 511-518.
13. + Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy. J. Immunol. 166: 5883-5888.
14. + T cells of Schwann cells expressing Mycobacterium leprae antigens. Eur. J. Immunol. 18: 969-972.
15. Dang, I., and G. H. DeVries. 2005. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB. J. Neurosci. Res. 79: 318-328.
16. Badache, A., N. Muja, and G. H. De Vries. 1998. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis. Oncogene 17: 795-800.
17. Im, J. S., K. O. Yu, P. A. Illarionov, K. P. LeClair, J. R. Storey, M. W. Kennedy, G. S. Besra, and S. A. Porcelli. 2004. Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. J. Biol. Chem. 279: 299-310.
18. - T cells. J. Exp. Med. 186: 109-120.
19. Exley, M., J. Garcia, S. B. Wilson, F. Spada, D. Gerdes, S. M. Tahir, K. T. Patton, R. S. Blumberg, S. Porcelli, A. Chott, and S. P. Balk. 2000. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 100: 37-47.
20. Spada, F. M., F. Borriello, M. Sugita, G. F. Watts, Y. Koezuka, and S. A. Porcelli. 2000. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur. J. Immunol. 30: 3468-3477.
21. Fregien, N. L., L. A. White, M. B. Bunge, and P. M. Wood. 2005. Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA. Glia 49: 24-35.
22. Lck-dependent pathway from leprosy bacilli. Proc. Natl. Acad. Sci. USA 102: 9188-9193.
23. Bonish, B., D. Jullien, Y. Dutronc, B. B. Huang, R. Modlin, F. M. Spada, S. A. Porcelli, and B. J. Nickoloff. 2000. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-γ production by NK-T cells. J. Immunol. 165: 4076-4085.
24. Spada, F. M., Y. Koezuka, and S. A. Porcelli. 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188: 1529-1534.
25. - α/β T cells with specificity for the mycobacterial 65 kd heat shock protein. Int. Immunol. 2: 279-284.
26. Inoue, M., T. Kanto, H. Miyatake, I. Itose, M. Miyazaki, T. Yakushijin, M. Sakakibara, N. Kuzushita, N. Hiramatsu, T. Takehara, A. Kasahara, and N. Hayashi. 2006. Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection. J. Hepatol. 45: 190-196.
27. + NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15: 279-288.
28. Gansert, J. L., V. Kiessler, M. Engele, F. Wittke, M. Rollinghoff, A. M. Krensky, S. A. Porcelli, R. L. Modlin, and S. Stenger. 2003. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol. 170: 3154-3161.
29. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
30. Oliveira, M. A., C. E. Tadokoro, G. M. Lima, T. Mosca, L. Q. Vieira, P. J. Leenen, and I. A. Abrahamsohn. 2005. Macrophages at intermediate stage of maturation produce high levels of IL-12 p40 upon stimulation with Leishmania. Microbes Infect. 7: 213-223.
31. Kang, T. J., S. B. Lee, and G. T. Chae. 2002. A polymorphism in the Toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 20: 56-62.
32. Ohyama, H., N. Kato, K. Takeuchi, Y. Soga, Y. Uemura, F. Nishimura, and S. Matsushita. 2004. Monocytes of distinct clinical types of leprosy are differentially activated by cross-linking class II HLA molecules to secrete IL-12. APMIS 112: 271-274.
33. Maeda, Y., M. Gidoh, N. Ishii, C. Mukai, and M. Makino. 2003. Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens. Cell. Immunol. 222: 69-77.
34. Durante-Mangoni, E., R. Wang, A. Shaulov, Q. He, I. Nasser, N. Afdhal, M. J. Koziel, and M. A. Exley. 2004. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 173: 2159-2166.
35. Kim, H. S., J. Garcia, M. Exley, K. W. Johnson, S. P. Balk, and R. S. Blumberg. 1999. Biochemical characterization of CD1d expression in the absence of β2-microglobulin. J. Biol. Chem. 274: 9289-9295.
36. Dhodapkar, K. M., B. Cirignano, F. Chamian, D. Zagzag, D. C. Miller, J. L. Finlay, and R. M. Steinman. 2004. Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion. Int. J. Cancer 109: 893-899.
37. Boyson, J. E., B. Rybalov, L. A. Koopman, M. Exley, S. P. Balk, F. K. Racke, F. Schatz, R. Masch, S. B. Wilson, and J. L. Strominger. 2002. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc. Natl. Acad. Sci. USA 99: 13741-13746.
38. de Lalla, C., G. Galli, L. Aldrighetti, R. Romeo, M. Mariani, A. Monno, S. Nuti, M. Colombo, F. Callea, S. A. Porcelli, et al. 2004. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J. Immunol. 173: 1417-1425.
39. Huber, S. A., and D. Sartini. 2005. Roles of tumor necrosis factor α (TNF-α) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis. J. Virol. 79: 2659-2665.
40. Armati, P. J., J. D. Pollard, and P. Gatenby. 1990. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 13: 106-116.
41. Lilje, O., and P. J. Armati. 1997. The distribution and abundance of MHC and ICAM-1 on Schwann cells in vitro. J. Neuroimmunol. 77: 75-84.
42. Tsuyuki, Y., H. Fujimaki, N. Hikawa, K. Fujita, T. Nagata, and M. Minami. 1998. IFN-γ induces coordinate expression of MHC class I-mediated antigen presentation machinery molecules in adult mouse Schwann cells. Neuroreport 9: 2071-2075.
43. Lilje, O. 2002. The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell. Mol. Life Sci. 59: 2191-2198.
44. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166: 6012-6018.
45. Kaneda, H., K. Takeda, T. Ota, Y. Kaduka, H. Akiba, Y. Ikarashi, H. Wakasugi, M. Kronenberg, K. Kinoshita, H. Yagita, and K. Okumura. 2005. ICOS costimulates invariant NKT cell activation. Biochem. Biophys. Res. Commun. 327: 201-207.
46. Zhou, D., J. Mattner, C. Cantu, III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
47. Joyce, S., A. S. Woods, J. W. Yewdell, J. R. Bennink, A. D. De Silva, A. Boesteanu, S. P. Balk, R. J. Cotter, and R. R. Brutkiewicz. 1998. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279: 1541-1544.
48. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221.
49. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
50. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
51. Terabe, M., S. Matsui, N. Noben-Trauth, H. Chen, C. Watson, D. D. Donaldson, D. P. Carbone, W. E. Paul, and J. A. Berzofsky. 2000. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1: 515-520.
52. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
53. Illes, Z., T. Kondo, J. Newcombe, N. Oka, T. Tabira, and T. Yamamura. 2000. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164: 4375-4381.
54. Mempel, M., B. Flageul, F. Suarez, C. Ronet, L. Dubertret, P. Kourilsky, G. Gachelin, and P. Musette. 2000. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas: presence of Vα24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Vα repertoire. Am. J. Pathol. 157: 509-523.
55. + invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 1117-1129.
56. Thomas, S. Y., R. Hou, J. E. Boyson, T. K. Means, C. Hess, D. P. Olson, J. L. Strominger, M. B. Brenner, J. E. Gumperz, S. B. Wilson, and A. D. Luster. 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171: 2571-2580.
57. Lee, P. T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195: 637-641.
58. Kim, C. H., E. C. Butcher, and B. Johnston. 2002. Distinct subsets of human Vα24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23: 516-519.
59. + NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11-16.
60. Mempel, M., C. Ronet, F. Suarez, M. Gilleron, G. Puzo, L. Van Kaer, A. Lehuen, P. Kourilsky, and G. Gachelin. 2002. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J. Immunol. 168: 365-371.